ObjectiveThe present study aimed the functional recovery evaluation after long term of
cardiac arrest induced by Custodiol (crystalloid-based)
versus del Nido (blood-based) solutions, both added
lidocaine and pinacidil as cardioplegic agents. Experiments were performed
in isolated rat heart perfusion models.MethodsMale rat heart perfusions, according to Langendorff technique, were induced
to cause 3 hours of cardiac arrest with a single dose. The hearts were
assigned to one of the following three groups: (I) control; (II)
Custodiol-LP; and (III) del Nido-LP. They were evaluated after ischemia
throughout 90 minutes of reperfusion. Left ventricular contractility
function was reported as percentage of recovery, expressed by developed
pressure, maximum dP/dt, minimum dP/dt, and rate pressure product variables.
In addition, coronary resistance and myocardial injury marker by
alpha-fodrin degradation were also evaluated.ResultsAt 90 minutes of reperfusion, both solutions had superior left ventricular
contractile recovery function than the control group. Del Nido-LP was
superior to Custodiol-LP in maximum dP/dt (46%±8 vs.
67%±7, P<0.05) and minimum dP/dt (31%±4
vs. 51%±9, P<0.05)
variables. Coronary resistance was lower in del Nido-LP group than in
Custodiol-LP (395%±50 vs. 307%±13,
P<0.05), as well as alpha-fodrin degradation, with
lower levels in del Nido-LP group (P<0.05).ConclusionDel Nido-LP cardioplegia showed higher functional recovery after 3 hours of
ischemia. The analysis of alpha-fodrin degradation showed del Nido-LP
solution provided greater protection against myocardial ischemia and
reperfusion (IR) in this experimental model.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.